Table 2.
Mean liver dose (MLD) and proportion of circulating lymphocytes receiving ≥0.5Gy (CL0.5) by intrahepatic locations as a mean for all treatment modalities and beam energies
2. Dependence on tumor location | ||
---|---|---|
Tumor location | MLD | CL0.5 |
Apical | 3.1 Gy | 18.8% |
Basal | 3.4 Gy | 19.0% |
Central | 5.3 Gy | 31.3% |